WZ811
CAS: 55778-02-4
Ref. 3D-FCA77802
| 5mg | A consultar | |
| 10mg | A consultar | |
| 25mg | A consultar | |
| 50mg | A consultar | |
| 100mg | A consultar |
Informação sobre produto
- N1,N4-Di-2-pyridinyl-1,4-benzenedimethanamine
- 1,4-benzenedimethanamine, N1,N4-di-2-pyridinyl-
- Wz 811
WZ811 is a small-molecule drug that has been shown to have therapeutic effects in a number of autoimmune diseases, such as bowel disease and multiple sclerosis. It binds to chemokine receptors on the surface of immune cells and blocks the binding of chemokines, preventing the release of inflammatory cytokines. WZ811 also prevents neuronal death by inhibiting toll-like receptor 4 (TLR4) signaling pathways. WZ811 has not been tested in humans yet but has shown promising results in vitro assays and in animal models. The compound is being studied for its potential use as a diagnostic agent for brain cancer. This drug has not been tested for toxicity or side effects with regards to HIV infection or other blood disorders.
Propriedades químicas
Consulta técnica sobre: 3D-FCA77802 WZ811
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
